H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 150 Citations 77,177 822 World Ranking 429 National Ranking 260

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

The scientist’s investigation covers issues in Internal medicine, Leukemia, Chronic lymphocytic leukemia, Gastroenterology and Immunology. His Internal medicine research incorporates elements of Surgery and Oncology. His studies in Leukemia integrate themes in fields like Survival rate, Myeloid leukemia, Pharmacology and Lymphoma.

Michael J. Keating has included themes like Cancer research, microRNA and Minimal residual disease in his Chronic lymphocytic leukemia study. He has researched Gastroenterology in several fields, including Refractory, Chronic myelogenous leukemia, Toxicity, Acute lymphocytic leukemia and Acute leukemia. Michael J. Keating interconnects Cytotoxic T cell and Glutathione in the investigation of issues within Immunology.

His most cited work include:

  • Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia (4145 citations)
  • Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines (2519 citations)
  • Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy (1097 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Chronic lymphocytic leukemia, Immunology, Leukemia and Gastroenterology. His Internal medicine study combines topics from a wide range of disciplines, such as Surgery and Oncology. His Chronic lymphocytic leukemia research is multidisciplinary, incorporating perspectives in Cancer, Cancer research and Pathology.

His Immunology research focuses on Myeloid leukemia in particular. His Leukemia study integrates concerns from other disciplines, such as Lymphoma, Bone marrow and Pharmacology. Michael J. Keating combines subjects such as Phases of clinical research, Cytarabine, Regimen, Neutropenia and Acute lymphocytic leukemia with his study of Gastroenterology.

He most often published in these fields:

  • Internal medicine (40.14%)
  • Chronic lymphocytic leukemia (37.04%)
  • Immunology (24.12%)

What were the highlights of his more recent work (between 2014-2021)?

  • Chronic lymphocytic leukemia (37.04%)
  • Internal medicine (40.14%)
  • Ibrutinib (6.43%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Chronic lymphocytic leukemia, Internal medicine, Ibrutinib, Cancer research and Oncology. A component of his Chronic lymphocytic leukemia study involves Leukemia and Immunology. Michael J. Keating focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Gastroenterology and, in certain cases, Phases of clinical research.

His research in Ibrutinib intersects with topics in Discontinuation, Obinutuzumab, Venetoclax, Pharmacology and Bruton's tyrosine kinase. His Cancer research research integrates issues from Apoptosis, STAT3, breakpoint cluster region and Bone marrow. His research investigates the connection between Oncology and topics such as Clinical trial that intersect with problems in Adverse effect.

Between 2014 and 2021, his most popular works were:

  • iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL (392 citations)
  • Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors (305 citations)
  • Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia (296 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Michael J. Keating focuses on Chronic lymphocytic leukemia, Internal medicine, Ibrutinib, Leukemia and Cancer research. His Chronic lymphocytic leukemia research is within the category of Immunology. His Internal medicine research is multidisciplinary, relying on both Surgery and Oncology.

His research integrates issues of Venetoclax, Tyrosine kinase, Bruton's tyrosine kinase and Pharmacology in his study of Ibrutinib. The study incorporates disciplines such as Targeted therapy, Malignancy, Lipoprotein lipase and Intensive care medicine in addition to Leukemia. His Cancer research research focuses on STAT3 and how it connects with Chromatin immunoprecipitation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

George Adrian Calin;Calin Dan Dumitru;Masayoshi Shimizu;Roberta Bichi.
Proceedings of the National Academy of Sciences of the United States of America (2002)

6223 Citations

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

Michael Hallek;Bruce D. Cheson;Daniel Catovsky;Federico Caligaris-Cappio.
Blood (2008)

4108 Citations

The New Regionalism in Western Europe: Territorial Restructuring and Political Change

Michael J. Keating.
(2000)

2298 Citations

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

Sergio Giralt;Elihu Estey;Maher Albitar;Koen Van Besien.
Blood (1997)

1458 Citations

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

I F Khouri;M Keating;M Körbling;D Przepiorka.
Journal of Clinical Oncology (1998)

1424 Citations

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

Michael J. Keating;Susan O'Brien;Maher Albitar;Susan Lerner.
Journal of Clinical Oncology (2005)

1238 Citations

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.

Michael J. Keating;Ian Flinn;Vinay Jain;Jacques-Louis Binet.
Blood (2002)

1190 Citations

Nations Against the State: The New Politics of Nationalism in Quebec, Catalonia and Scotland

Michael James Keating.
(1996)

1161 Citations

ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia

Laura Z. Rassenti;Lang Huynh;Tracy L. Toy;Liguang Chen.
The New England Journal of Medicine (2004)

1131 Citations

Superoxide dismutase as a target for the selective killing of cancer cells

Peng Huang;Li Feng;Elizabeth A. Oldham;Michael J. Keating.
Nature (2000)

1091 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael J. Keating

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 643

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 388

Susan O'Brien

Susan O'Brien

University of California, Irvine

Publications: 353

John C. Byrd

John C. Byrd

University of Cincinnati

Publications: 310

Michael Hallek

Michael Hallek

University of Cologne

Publications: 238

Farhad Ravandi

Farhad Ravandi

The University of Texas MD Anderson Cancer Center

Publications: 225

Guillermo Garcia-Manero

Guillermo Garcia-Manero

The University of Texas MD Anderson Cancer Center

Publications: 212

Elias Jabbour

Elias Jabbour

The University of Texas MD Anderson Cancer Center

Publications: 207

Carlo M. Croce

Carlo M. Croce

The Ohio State University

Publications: 205

George A. Calin

George A. Calin

The University of Texas MD Anderson Cancer Center

Publications: 204

Stephan Stilgenbauer

Stephan Stilgenbauer

University of Ulm

Publications: 198

Tadeusz Robak

Tadeusz Robak

Medical University of Lodz

Publications: 196

Thomas J. Kipps

Thomas J. Kipps

University of California, San Diego

Publications: 187

Francis J. Giles

Francis J. Giles

National University of Ireland, Galway

Publications: 185

Gianluca Gaidano

Gianluca Gaidano

University of Eastern Piedmont Amadeo Avogadro

Publications: 169

Elihu H. Estey

Elihu H. Estey

Fred Hutchinson Cancer Research Center

Publications: 162

Something went wrong. Please try again later.